NCT04128748 2026-06-02Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic SyndromeM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting52 enrolled